Piroxicam and meloxicam ameliorate hepatic oxidative stress and protein carbonylation in Kupffer and sinusoidal endothelial cells promoted by ischemia-reperfusion injury

Transplant International

Volumn 24, Issue 5, 2011, Pages 489-500

  Montalvo Javé, Eduardo E ^a,b,c,d   Ortega Salgado, José A ^a   Castell, Andrés ^b   Carrasco Daza, Daniel ^e   Jay, David ^f   Gleason, Roberto ^a   Muñoz, Eduardo ^a   Montalvo Arenas, César ^b   Hernández Muñoz, Rolando ^g   Piña, Enrique ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^d HOSPITAL GENERAL DE MÉXICO   (Mexico)

^e INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^f UNIVERSITY OF ALBERTA   (Canada)

^g INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

Electron paramagnetic resonance; Ischemia reperfusion injury; Kupffer cells; Liver; Nonsteroidal anti inflammatory drugs; Protein carbonylation; Reactive oxygen species; Sinusoidal endothelial cells

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; ORNITHINE CARBAMOYLTRANSFERASE; PIROXICAM; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CATALYSIS; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENDOTHELIUM CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; ISCHEMIA; KUPFFER CELL; LIPID PEROXIDATION; LIVER FUNCTION; LIVER INJURY; LIVER ISCHEMIA; LIVER PARENCHYMA; LIVER SINUSOID; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT; REPERFUSION INJURY;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPARTATE AMINOTRANSFERASES; CARBON; ENDOTHELIAL CELLS; HUMANS; KUPFFER CELLS; L-LACTATE DEHYDROGENASE; LIVER; ORNITHINE CARBAMOYLTRANSFERASE; OXIDATIVE STRESS; PIROXICAM; PROTEINS; RATS; RATS, WISTAR; REPERFUSION INJURY; THIAZINES; THIAZOLES;

EID: 79953778416     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01214.x     Document Type: Article

References (62)

1. Montalvo-Javé EE, Escalante-Tattersfield T, Ortega-Salgado JA, Piña E, Geller DA. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res 2008; 147: 153.
2. Bilzer M, Gerbes AL. Preservation injury of the liver: mechanisms and novel therapeutic strategies. J Hepatol 2000; 32: 508.
3. Wisse E, De Zanger RB, Charels K, Van Der Smissen P, McCuskey RS. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 1985; 5: 683.
4. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology 1989; 10: 292.
5. McKeown CM, Edwards V, Phillips MJ, Harvey PR, Petrunka CN, Strasberg SM. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation 1988; 46: 178.
6. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15.
7. Kim JS, Jin Y, Lemasters JJ. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2006; 290: H2024.
8. Mosher B, Dean R, Harkema J, Remick D, Palma J, Crockett E. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J Surg Res 2001; 99: 201.
9. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia- reperfusion injury. Am J Surg 2001; 181: 160.
10. Sindram D, Porte RJ, Hoffman MR, Bentley RC, Clavien PA. Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. Gastroenterology 2000; 118: 183.
11. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998; 27: 1652.
12. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J 1998; 12: 1063.
13. Turnage RH, Kadesky KM, Bartula L, Myers SI. Pulmonary thromboxane release following intestinal reperfusion. J Surg Res 1995; 58: 552.
14. Hossain MA, Wakabayashi H, Izuishi K, Okano K, Yachida S, Maeta H. The role of prostaglandins in liver ischemia-reperfusion injury. Curr Pharm Des 2006; 12: 2935.
15. Arii S, Teramoto K, Kawamura T. Current progress in the understanding of and therapeutic strategies for ischemia and reperfusion injury of the liver. J Hepatobiliary Pancreat Surg 2003; 10: 189.
16. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246.
17. Wood KC, Gladwin MT. The hydrogen highway to reperfusion therapy. Nat Med 2007; 13: 673.
18. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006; 43: S31.
19. Nystrom T. Role of oxidative carbonylation in protein quality control and senescence. EMBO J 2005; 24: 1311.
20. Levine RL. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 2002; 32: 790.
21. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003; 9: 169.
22. Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 2006; 10: 389.
23. Wang D, Mann JR, DuBois RN. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology 2005; 128: 1445.
24. Morham SG, Langenbach R, Loftin CD, et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995; 83: 473.
25. Berg DJ, Zhang J, Weinstock JV, et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 2002; 123: 1527.
26. Smith WL, Meade EA, DeWitt DL. Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. Ann N Y Acad Sci 1994; 744: 50.
27. Pairet M, van Ryn J, Schierok H, Mauz A, Trummlitz G, Engelhardt G. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4′-isomer. Inflamm Res 1998; 47: 270.
28. Zentella de Piña M, Sandoval-Montiel A, Serrano- Alessandri L, Montalvo-Javé E, Zentella-Dehesa A, Piña E. Ethanol-mediated oxidative changes in blood lipids and proteins are reversed by aspirin-like drugs. Arch Med Res 2007; 38: 269.
29. Saldaña-Balmori Y, Zentella de Piña M, Guinzberg R, Rocha-Hernández A, Piña E. Piroxicam modifies the effects of ethanol on isolated rat hepatocytes. Eur J Pharmacol 1996; 317: 225.
30. Zentella de Piña M, Corona S, Rocha-Hernández AE, Saldan ̃a-Balmori Y, Cabrera G, Piña E. Restoration by piroxicam of liver glutathione levels decreased by acute ethanol intoxication. Life Sci 1994; 54: 1433.
31. Zentella de Piña M, Saldaña-Balmori Y, Hernández- Tobias A, Piña E. Nonsteroidal antiinflammatory drugs lower ethanol-mediated liver increase in lipids and thiobarbituric acid reactive substances. Alcohol Clin Exp Res 1993; 17: 1228.
32. Zentella de Piña M, Hernández-Tobias A, Saldaña- Balmori Y, Díaz-Belmont A, Piña E. Biochemical ethanol effects affected by a non-steroidal anti-inflammatory drug. FEBS Lett 1992; 298: 123.
33. Hernández-Muñoz R, Díaz-Muñoz M, Suárez J, Chagoya de Sánchez V. Adenosine partially prevents cirrhosis induced by carbon tetrachloride in rats. Hepatology 1990; 12: 242.
34. Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Sugimachi K. Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 1992; 16: 454.
35. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696.
36. Wilbur KM, Bernheim F, Shapiro OW. The thiobarbituric acid reagent as a test for the oxidation of unsaturated fatty acids by various agents. Arch Biochem 1949; 24: 305.
37. Smith MA, Sayre LM, Anderson VE, et al. Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine. J Histochem Cytochem 1998; 46: 731.
38. Corona-Morales AA, Castell A, Zhang L. L-DOPA-induced neurotoxic and apoptotic changes on cultured chromaffin cells. Neuroreport 2000; 11: 503.
39. Wright G, Terada K, Yano M, Sergeev I, Mori M. Oxidative stress inhibits the mitochondrial import of preproteins and leads to their degradation. Exp Cell Res 2001; 263: 107.
40. Díaz-Juárez J, Rivera-Valerdi L, Bernal-Cerrillo DE, Hernández-Muñoz R. Predominance of released mitochondrial enzymes by partial hepatectomy-induced rat regenerating liver is controlled by hemodynamic changes and not related to mitochondrial damage. Scand J Gastroenterol 2006; 41: 223.
41. Pringle JH. V. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 1908; 48: 541.
42. Garcea G, Gescher A, Steward W, Dennison A, Berry D. Oxidative stress in humans following the Pringle manoeuvre. Hepatobiliary Pancreat Dis Int 2006; 5: 210.
43. Richardson JD. Changes in the management of injuries to the liver and spleen. J Am Coll Surg 2005; 200: 648.
44. Tsung A, Geller DA. Workup of the incidental liver lesion. Adv Surg 2005; 39: 331.
45. Belghiti J, Noun R, Malafosse R, et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 1999; 229: 369.
46. Clavien PA, Emond J, Vauthey JN, Belghiti J, Chari RS, Strasberg SM. Protection of the liver during hepatic surgery. J Gastrointest Surg 2004; 8: 313.
47. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917.
48. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology 1991; 13: 83.
49. Cavalieri B, Mosca M, Ramadori P, et al. Neutrophil recruitment in the reperfused-injured rat liver was effectively attenuated by repertaxin, a novel allosteric noncompetitive inhibitor of CXCL8 receptors: a therapeutic approach for the treatment of post-ischemic hepatic syndromes. Int J Immunopathol Pharmacol 2005; 18: 475.
50. Colletti LM, Kunkel SL, Walz A, et al. The role of cytokine networks in the local liver injury following hepatic ischemia/ reperfusion in the rat. Hepatology 1996; 23: 506.
51. Frank J, Pompella A, Biesalski HK. Histochemical visualization of oxidant stress. Free Radic Biol Med 2000; 29: 1096.
52. Fukai M, Hayashi T, Yokota R, et al. Lipid peroxidation during ischemia depends on ischemia time in warm ischemia and reperfusion of rat liver. Free Radic Biol Med 2005; 38: 1372.
53. Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 2008; 283: 21837.
54. De Vries J, De Jong J, Lock FM, Van Bree L, Mullink H, Veldhuizen RW. Protection against paracetamol-induced hepatotoxicity by acetylsalicylic acid in rats. Toxicology 1984; 30: 297.
55. Wu KK. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. Semin Vasc Med 2003; 3: 107.
56. Imaeda AB, Watanabe A, Sohail MA, et al. Acetaminophen- induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 2009; 119: 305.
57. Hamada T, Tsuchihashi S, Avanesyan A, et al. Cyclooxygenase- 2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/ reperfusion injury. J Immunol 2008; 180: 1843.
58. Ozturk H, Gezici A. The effect of celecoxib, a selective COX-2 inhibitor, on liver ischemia/reperfusion-induced oxidative stress in rats. Hepatol Res 2006; 34: 76.
59. Warner TD, Mitchell JA. COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs. Lancet 2008; 371: 270.
60. Targownik LE, Metge CJ, Leung S, Chateau DG. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Gastroenterology 2008; 134: 937.
61. Strand V. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin? Lancet 2007; 370: 2138.
62. Warner TD, Vojnovic I, Bishop-Bailey D, Mitchell JA. Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2. FASEB J 2006; 20: 542.